Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond

Cardiomyopathy is caused by functional abnormality of cardiac muscle. The functional abnormality involved in its etiology includes both extrinsic and intrinsic factors, and cardiomyopathy caused by the intrinsic factors is called as idiopathic or primary cardiomyopathy. There are several clinical types of primary cardiomyopathy including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Linkage studies and candidate gene approaches have explored the disease genes for hereditary primary cardiomyopathy. The most notable finding was that mutations in the same disease gene can be found in different clinical types of cardiomyopathy. Functional analyses of disease-related mutations have revealed that characteristic functional alterations are associated with the clinical types, such that increased and decreased Ca2+ sensitivity due to sarcomere mutations are associated with HCM and DCM, respectively. In addition, our recent studies have suggested that mutations in the Z-disc components found in HCM and DCM may result in increased and decreased stiffness of sarcomere; that is, stiff sarcomere and loose sarcomere, respectively, and hence altered stretch response. More recently, mutations in the components of I region were found in hereditary cardiomyopathy and the functional analyses of the mutations suggested that the altered stress response was associated with cardiomyopathy, further complicating the etiology and pathogenesis. However, elucidation of genetic etiology and functional alterations caused by the mutations shed lights on the new therapeutic approaches to hereditary cardiomyopathy, such that treatment of DCM with a Ca2+ sensitizer prevented the disease in a mouse model.

[1]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[2]  K. Ueda,et al.  Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. , 2004, Biochemical and biophysical research communications.

[3]  Takeharu Hayashi,et al.  Titin mutations as the molecular basis for dilated cardiomyopathy. , 2002, Biochemical and biophysical research communications.

[4]  Walter Birchmeier,et al.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.

[5]  Christian C. Witt,et al.  Dimerization of the cardiac ankyrin protein CARP: Implications for MARP titin-based signaling , 2006, Journal of Muscle Research & Cell Motility.

[6]  J. Towbin,et al.  1854 X-Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy ( Dystrophin ) Gene at the Xp 21 Locus , 2005 .

[7]  T. Sasazuki,et al.  A missense mutation of cardiac beta-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families. , 1993, Biochemical and biophysical research communications.

[8]  N. Schork,et al.  Laminin-&agr;4 and Integrin-Linked Kinase Mutations Cause Human Cardiomyopathy Via Simultaneous Defects in Cardiomyocytes and Endothelial Cells , 2007 .

[9]  T. Sasazuki,et al.  Possible Gene Effect of a Mutant Cardiac β-Myosin Heavy Chain Gene on the Clinical Expression of Familial Hypertrophic Cardiomyopathy , 1994 .

[10]  Masahiko Hoshijima,et al.  Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery , 2002, Nature Medicine.

[11]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[12]  Gian Antonio Danieli,et al.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.

[13]  E. McNally,et al.  The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.

[14]  C. Long,et al.  Prevalence of Desmin Mutations in Dilated Cardiomyopathy , 2007, Circulation.

[15]  T. Ogihara,et al.  Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy. , 2007, American journal of physiology. Heart and circulatory physiology.

[16]  M. Komajda,et al.  Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. , 2008, Cardiovascular research.

[17]  O. Roopnarine Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy. , 2003, Biophysical journal.

[18]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[19]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[20]  J. Towbin,et al.  Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome , 2001, Circulation.

[21]  T. Kubo,et al.  Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese. , 2005, Journal of the American College of Cardiology.

[22]  V. Rosen,et al.  Heart specific expression of mouse BMP-10 a novel member of the TGF-β superfamily , 1999, Mechanisms of Development.

[23]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[24]  B. Maron,et al.  A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. , 1998, Circulation research.

[25]  M Hiroe,et al.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. , 1999, Biochemical and biophysical research communications.

[26]  T. Arimura,et al.  Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. , 2007, Biochemical and biophysical research communications.

[27]  D. Kelsell,et al.  Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome , 2005, Journal of Medical Genetics.

[28]  P. Elliott,et al.  Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.

[29]  I. Grupp,et al.  The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility , 2004, Basic Research in Cardiology.

[30]  Y. Hayashizaki,et al.  Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human molecular genetics.

[31]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[32]  R. Dietz,et al.  Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy , 2003, Circulation.

[33]  S. Thibodeau,et al.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.

[34]  N. Hattori,et al.  Mutational analysis of fukutin gene in dilated cardiomyopathy and hypertrophic cardiomyopathy. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[35]  S. Odelberg,et al.  Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice , 2007, Cell.

[36]  T. Arimura,et al.  Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model. , 2010, Journal of the American College of Cardiology.

[37]  F. Muntoni,et al.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy , 2004, Heart.

[38]  Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy , 2000 .

[39]  Dietmar Labeit,et al.  Titin isoform-dependent effect of calcium on passive myocardial tension. , 2004, American journal of physiology. Heart and circulatory physiology.

[40]  W. Edwards,et al.  A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. , 2006, Biochemical and biophysical research communications.

[41]  T. Imaizumi,et al.  A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. , 1995, Circulation.

[42]  L. Monserrat,et al.  Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. , 2004, The American journal of cardiology.

[43]  Christine E Seidman,et al.  The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.

[44]  R. Goody,et al.  Noncompaction of the Ventricular Myocardium Is Associated with a De Novo Mutation in the β-Myosin Heavy Chain Gene , 2007, PloS one.

[45]  Qiang Zhou,et al.  Cypher, a Striated Muscle-restricted PDZ and LIM Domain-containing Protein, Binds to α-Actinin-2 and Protein Kinase C* , 1999, The Journal of Biological Chemistry.

[46]  D. Spodick,et al.  Restrictive cardiomyopathy. , 1997, The New England journal of medicine.

[47]  G. Valle,et al.  Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.

[48]  T. Hewett,et al.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.

[49]  A. Kimura Molecular etiology and pathogenesis of hereditary cardiomyopathy. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[50]  Hiroki Shibata,et al.  Alpha B-crystallin mutation in dilated cardiomyopathy. , 2006, Biochemical and biophysical research communications.

[51]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[52]  Paul Young,et al.  Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly , 2001, The Journal of cell biology.

[53]  M. Durán,et al.  X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update , 2004, American journal of medical genetics. Part A.

[54]  L. Mestroni,et al.  Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.

[55]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[56]  L. Leinwand,et al.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.

[57]  I. Rayment,et al.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Kelsell,et al.  Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.

[59]  U. Moens,et al.  The multifunctional roles of the four-and-a-half-LIM only protein FHL2 , 2006, Cellular and Molecular Life Sciences CMLS.

[60]  P. Burch,et al.  Desmin mutation responsible for idiopathic dilated cardiomyopathy. , 1999, Circulation.

[61]  S. Solomon,et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.

[62]  T. Arimura,et al.  Structural analysis of obscurin gene in hypertrophic cardiomyopathy. , 2007, Biochemical and biophysical research communications.

[63]  A. Børglum,et al.  Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[64]  P. Elliott,et al.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.

[65]  Yuan-Ping Pang,et al.  ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.

[66]  D. Martyn,et al.  Length-dependent Ca2+ activation in cardiac muscle: some remaining questions , 2005, Journal of Muscle Research & Cell Motility.

[67]  S. Varnous,et al.  Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. , 2005, Human molecular genetics.

[68]  R. Nagai,et al.  Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. , 2000, Hypertension.

[69]  J. Frydman,et al.  Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation , 2005, The FEBS journal.

[70]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[71]  Masahiko Hoshijima,et al.  Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[72]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[73]  V Fuster,et al.  Restrictive cardiomyopathy. , 1997, The New England journal of medicine.

[74]  G. Dorn,et al.  A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[75]  L. Monserrat,et al.  Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN –42 C>G mutation , 2007, European journal of heart failure.

[76]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[77]  S. Rosenheck,et al.  Arrhythmogenic Right Ventricular Dysplasia A Recessive Mutation in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia, Skin Disorder, and Woolly Hair , 2003 .

[78]  T. Imaizumi,et al.  Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene. , 1996, Journal of cardiac failure.

[79]  J. Finsterer,et al.  The Heart in Human Dystrophinopathies , 2003, Cardiology.

[80]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[81]  F. Takahashi‐Yanaga,et al.  Ca2+-desensitizing effect of a deletion mutation ΔK210 in cardiac troponin T that causes familial dilated cardiomyopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M. Davies,et al.  Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C* , 2001, The Journal of Biological Chemistry.

[83]  T. Hewett,et al.  Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .

[84]  村上 てるみ Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness , 2006 .

[85]  Qiang Zhou,et al.  A Cypher/ZASP Mutation Associated with Dilated Cardiomyopathy Alters the Binding Affinity to Protein Kinase C* , 2004, Journal of Biological Chemistry.

[86]  D. Schaid,et al.  Frequency of familial dilated cardiomyopathy. , 1995, European heart journal.

[87]  L. Mestroni,et al.  Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.

[88]  J. Towbin,et al.  Genetic abnormalities responsible for dilated cardiomyopathy , 2000, Current cardiology reports.

[89]  K. Nagata,et al.  Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. , 2005, Biochemical and biophysical research communications.

[90]  A. Ciccodicola,et al.  Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the disease. , 1995, Human molecular genetics.

[91]  Carlos A. Dumont,et al.  Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. , 2007, European heart journal.

[92]  L. Mestroni,et al.  Clinical StudiesFamilial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity☆ , 1999 .

[93]  E. Olson,et al.  Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[94]  J. Potter,et al.  Sarcomeric Protein Mutations in Dilated Cardiomyopathy , 2005, Heart Failure Reviews.

[95]  K. Osterziel,et al.  Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and α-actinin and their implication for hypertrophic cardiomyopathy , 2004, Cell and Tissue Research.

[96]  J. Mogensen,et al.  Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy , 2004, The Lancet.

[97]  I. Ohtsuki,et al.  Ca2+ Sensitization and Potentiation of the Maximum Level of Myofibrillar ATPase Activity Caused by Mutations of Troponin T Found in Familial Hypertrophic Cardiomyopathy* , 1999, The Journal of Biological Chemistry.

[98]  G. Dorn,et al.  Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. , 1996, The Journal of clinical investigation.

[99]  J. Towbin,et al.  Chapter 3 Cardiac Ankyrin Repeat Protein Gene ( ANKRD 1 ) Mutations in Hypertrophic Cardiomyopathy , 2010 .

[100]  T. Arimura,et al.  Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy , 2006, Journal of Muscle Research & Cell Motility.

[101]  T. Irving,et al.  Titin-Based Modulation of Calcium Sensitivity of Active Tension in Mouse Skinned Cardiac Myocytes , 2001, Circulation research.

[102]  J. Seidman,et al.  Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly , 2002, Circulation.

[103]  J. Towbin,et al.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.

[104]  Michael J Ackerman,et al.  Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function , 2007, Circulation.

[105]  Michael D. Schneider,et al.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis , 2004, Development.

[106]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[107]  J. Potter,et al.  A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin* , 2008, Journal of Biological Chemistry.

[108]  R. Schwartz,et al.  Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. , 2003, Molecular genetics and metabolism.

[109]  J. Towbin,et al.  Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. , 2009, Cardiovascular research.

[110]  Michael J Ackerman,et al.  A Functional and Structural Study of Troponin C Mutations Related to Hypertrophic Cardiomyopathy* , 2009, The Journal of Biological Chemistry.

[111]  F. Tesson,et al.  Lamin A/C and cardiac diseases , 2006, Current opinion in cardiology.

[112]  S. Ommen,et al.  Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. , 2007, Journal of molecular and cellular cardiology.

[113]  L. Mestroni,et al.  SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia , 2004, Circulation.

[114]  J. Molkentin,et al.  Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. , 2004, Biochemical and biophysical research communications.

[115]  M. Keating,et al.  Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy , 2002, Circulation.

[116]  S. Manilal,et al.  Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy. , 1999, Human molecular genetics.

[117]  T. Imaizumi,et al.  Adenovirus-Mediated Overexpression of Caveolin-3 Inhibits Rat Cardiomyocyte Hypertrophy , 2003, Hypertension.

[118]  F. Takahashi‐Yanaga,et al.  SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure. , 2005, Journal of pharmacological sciences.

[119]  W. Lee,et al.  Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family. , 1998, The American journal of cardiology.

[120]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[121]  R. Hauer,et al.  Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon? , 2007, Current opinion in cardiology.

[122]  J. Towbin,et al.  ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. , 2009, Journal of the American College of Cardiology.

[123]  J. Seidman,et al.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. , 2000, Circulation research.

[124]  T. Sasazuki,et al.  Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. , 1994, Biochemical and biophysical research communications.

[125]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[126]  Christine E Seidman,et al.  Phenotypic diversity in hypertrophic cardiomyopathy. , 2002, Human molecular genetics.

[127]  R. Matsuoka,et al.  Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. , 2003, Biochemical and biophysical research communications.

[128]  A. Børglum,et al.  α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy , 1999 .

[129]  K. Chien,et al.  Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. , 2006, Journal of the American College of Cardiology.

[130]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[131]  P. Caroni,et al.  Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[132]  Masahiko Hoshijima,et al.  The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy , 2002, Cell.

[133]  J. Arthur,et al.  Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.

[134]  N. Schork,et al.  Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. , 2007, Circulation.

[135]  H. Watkins,et al.  Altered Regulatory Properties of Human Cardiac Troponin I Mutants That Cause Hypertrophic Cardiomyopathy* , 2000, The Journal of Biological Chemistry.

[136]  J. Carey,et al.  Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. , 1997, American journal of human genetics.

[137]  J. Towbin,et al.  X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[138]  Paul Pavlidis,et al.  Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. , 2007, The Journal of clinical investigation.

[139]  J. Towbin,et al.  The failing heart , 2002, Nature.